Literature DB >> 16595438

Lumbar disc disorders and low-back pain: socioeconomic factors and consequences.

Jeffrey N Katz1.   

Abstract

Socioeconomic factors are important risk factors for lumbar pain and disability. The total costs of low-back pain in the United States exceed $100 billion per year. Two-thirds of these costs are indirect, due to lost wages and reduced productivity. Each year, the fewer than 5% of the patients who have an episode of low-back pain account for 75% of the total costs. Because indirect costs rely heavily on changes in work status, total costs are difficult to calculate for many women and students as well as elderly and disabled patients. These methodologic challenges notwithstanding, the toll of lumbar disc disorders is enormous, underscoring the critical importance of identifying strategies to prevent these disorders and their consequences.

Entities:  

Mesh:

Year:  2006        PMID: 16595438     DOI: 10.2106/JBJS.E.01273

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  487 in total

1.  Noninvasive Assessment of Biochemical and Mechanical Properties of Lumbar Discs Through Quantitative Magnetic Resonance Imaging in Asymptomatic Volunteers.

Authors:  Mary H Foltz; Craig C Kage; Casey P Johnson; Arin M Ellingson
Journal:  J Biomech Eng       Date:  2017-11-01       Impact factor: 2.097

2.  Restricting back pain and subsequent mobility disability in community-living older persons.

Authors:  Una E Makris; Liana Fraenkel; Ling Han; Linda Leo-Summers; Thomas M Gill
Journal:  J Am Geriatr Soc       Date:  2014-11-03       Impact factor: 5.562

3.  Nuclei pulposi formation from the embryonic notochord occurs normally in GDF-5-deficient mice.

Authors:  Jennifer A Maier; Brian D Harfe
Journal:  Spine (Phila Pa 1976)       Date:  2011-11-15       Impact factor: 3.468

4.  Restricting Back Pain and Subsequent Disability in Activities of Daily Living Among Community-Living Older Adults.

Authors:  Una E Makris; Mark A Weinreich; Liana Fraenkel; Ling Han; Linda Leo-Summers; Thomas M Gill
Journal:  J Aging Health       Date:  2017-09-01

Review 5.  Disc in flames: Roles of TNF-α and IL-1β in intervertebral disc degeneration.

Authors:  Z I Johnson; Z R Schoepflin; H Choi; I M Shapiro; M V Risbud
Journal:  Eur Cell Mater       Date:  2015-09-21       Impact factor: 3.942

6.  Injectable cellulose-based hydrogels as nucleus pulposus replacements: Assessment of in vitro structural stability, ex vivo herniation risk, and in vivo biocompatibility.

Authors:  Huizi Anna Lin; Devika M Varma; Warren W Hom; Michelle A Cruz; Philip R Nasser; Robert G Phelps; James C Iatridis; Steven B Nicoll
Journal:  J Mech Behav Biomed Mater       Date:  2019-04-17

7.  Reliability and validity study on the Hungarian versions of the oswestry disability index and the Quebec back pain disability scale.

Authors:  Tamás Valasek; Peter Paul Varga; Zsolt Szövérfi; Michelle Kümin; Jeremy Fairbank; Aron Lazary
Journal:  Eur Spine J       Date:  2013-01-16       Impact factor: 3.134

Review 8.  Chronic low back pain: a mini-review on pharmacological management and pathophysiological insights from clinical and pre-clinical data.

Authors:  Thomas S W Park; Andy Kuo; Maree T Smith
Journal:  Inflammopharmacology       Date:  2018-05-12       Impact factor: 4.473

9.  Multiplex Epigenome Editing of Dorsal Root Ganglion Neuron Receptors Abolishes Redundant Interleukin 6, Tumor Necrosis Factor Alpha, and Interleukin 1β Signaling by the Degenerative Intervertebral Disc.

Authors:  Joshua D Stover; Niloofar Farhang; Brandon Lawrence; Robby D Bowles
Journal:  Hum Gene Ther       Date:  2019-06-11       Impact factor: 5.695

10.  Evaluation of a new approach to compute intervertebral disc height measurements from lateral radiographic views of the spine.

Authors:  Brett T Allaire; M Clara DePaolis Kaluza; Alexander G Bruno; Elizabeth J Samelson; Douglas P Kiel; Dennis E Anderson; Mary L Bouxsein
Journal:  Eur Spine J       Date:  2016-10-18       Impact factor: 3.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.